Q2 Earnings Estimate for CLB Issued By Zacks Research

Core Laboratories Inc. (NYSE:CLB) – Investment analysts at Zacks Research issued their Q2 2026 EPS estimates for Core Laboratories in a report issued on Tuesday, May 19th. Zacks Research analyst Team anticipates that the oil and gas company will post earnings of $0.07 per share for the quarter. The consensus estimate for Core Laboratories’ current full-year earnings is $0.54 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2026 earnings at $0.18 EPS, Q4 2026 earnings at $0.27 EPS, FY2026 earnings at $0.57 EPS, Q1 2027 earnings at $0.10 EPS, Q2 2027 earnings at $0.28 EPS, Q3 2027 earnings at $0.21 EPS, Q4 2027 earnings at $0.24 EPS, FY2027 earnings at $0.83 EPS, Q1 2028 earnings at $0.23 EPS and FY2028 earnings at $1.10 EPS.

Several other brokerages have also commented on CLB. Wall Street Zen upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Sunday. Weiss Ratings downgraded Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $12.00.

Core Laboratories Trading Up 0.0%

Shares of CLB opened at $13.72 on Thursday. Core Laboratories has a 1-year low of $9.72 and a 1-year high of $20.36. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42. The firm’s 50-day moving average price is $15.78 and its 200-day moving average price is $16.70. The firm has a market capitalization of $632.54 million, a price-to-earnings ratio of 21.11, a PEG ratio of 2.72 and a beta of 0.99.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The business had revenue of $121.80 million for the quarter, compared to the consensus estimate of $122.99 million. During the same period in the previous year, the firm earned $0.14 EPS. The company’s quarterly revenue was down 1.4% compared to the same quarter last year. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS.

Core Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be given a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 11th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. Core Laboratories’s dividend payout ratio is currently 6.15%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Summit Securities Group LLC bought a new stake in Core Laboratories during the first quarter worth about $31,000. Aster Capital Management DIFC Ltd bought a new position in shares of Core Laboratories during the fourth quarter valued at approximately $34,000. Quarry LP lifted its holdings in shares of Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after purchasing an additional 1,599 shares during the last quarter. CWM LLC lifted its holdings in shares of Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock valued at $40,000 after purchasing an additional 668 shares during the last quarter. Finally, Hantz Financial Services Inc. boosted its position in shares of Core Laboratories by 124.7% in the 4th quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after purchasing an additional 1,763 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.